Patient P-01672
Synthetic patientNBL-101 · Day 120 · 45–54 · F · baseline S04Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
11%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S04
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Inflammatory activity-5
- Nutritional resilience+5
- GI instability-3
- Treatment adherence-2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion18.2/100
improving · -4.6 vs previous 14 d
Toxicity
Blood3.2/100
improving · -3.4 vs previous 14 d
Sleep quality
Wearable46.4/100
improving · +3.3 vs previous 14 d
Energy level
Daily log7.1/10
improving · +0.6 vs previous 14 d
Stress level
Daily log3.2/10
improving · -0.8 vs previous 14 d
Steps
Wearable5,107
stable · +186 vs previous 14 d
Adherence
Companion84.3 %
stable · +0.6 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 93 from the failing basin, 9 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
- Daily walks resumedperturbation · steering +3.3
Main detractors to watch
- Low microbial diversityhidden · steering -7.7
- Bacteroides fragilis elevatedhidden · steering -7.4
- Simple carbohydratesperturbation · steering -6.5
- Low-HRV stretchperturbation · steering -2.7
- Simple carbohydratesdetractor · GI +3.7 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Simple carbohydrates+3.7detractor · 95%
- Dietary fat load+2.4no signal · 50%
- Spicy / capsaicin+1.3no signal · 29%
- Histamine load-0.7no signal · 15%
- Alcohol+0.7no signal · 19%
- Insoluble fibre+0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↑45
- WearableResting HR 75 bpm
- WearableShort sleep window
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
- Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 2.9 · butyrate capacity 72/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 43 ms
- Sleep
- 6.5 h
- Steps
- 5,507
- Resting HR
- 74 bpm
Daily log: GI score 18, nutritional resilience 69, adherence 84.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.